Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website
Publication Briefs

Study Suggests Diffusion of New Drug Therapy for PTSD Lessens with Distance

With the growing emphasis on the delivery of evidence-based medicine, there has been increasing interest in identifying processes that facilitate the diffusion and dissemination of newly developed treatments from research into routine clinical practice. This study sought to evaluate the pace and reach of the passive dissemination of a novel, but as yet un-established treatment with the drug prazosin for post-traumatic stress disorder (PTSD) within the VA health care system. Prazosin has been used for many years in the treatment of hypertension, and several years ago researchers at the VA Puget Sound Healthcare System published an article on its effectiveness in treating nightmares and hyper-arousal associated with chronic PTSD. Investigators in this study used geographic surveillance data to track the diffusion of prazosin to treat Veterans diagnosed with PTSD in the VA Puget Sound Healthcare System, and at VAMCs located in four distance-defined groups ranging up to 2500 miles or farther from Puget Sound. Investigators also compared Veterans treated in mental health specialty programs with those treated exclusively in VA primary care or medical or surgical program locations. Veterans in this study cohort were diagnosed with PTSD in FY04 (n=203,414) and FY06 (n=319,670), and data were analyzed to show changes in the use of prazosin during this two-year period.

Findings show that the passive diffusion of a new treatment can be rapid in the immediate area in which it is developed, but the geographic gradient of use seems to be steep and changed little during a two-year period, even when cost and organizational barriers were minimal. Veterans with PTSD treated in the area nearest to Puget Sound (<499 miles) were about 63% less likely in 2004 and about 49% less likely in 2006 to be prescribed prazosin than their counterparts treated within Puget Sound. Moreover, whereas 37.6% of Veterans within Puget Sound were prescribed prazosin in 2004, only 18.2% were treated with prazosin at VA medical centers up to 499 miles away, 6.7% at centers 500 to 999 miles away, 4.0% at centers 1000 to 2499 miles away, and just 1.9% at centers 2500 miles away or farther. Most Veterans who were prescribed prazosin were treated in a mental health specialty clinic (92.9% in '04 and 86.7% in '06). These results suggest that if and when new treatments are definitively demonstrated to be effective, more active dissemination is likely to be needed, especially in geographically remote areas.

PubMed Logo Harpaz-Rotem I, Rosenheck R. Tracing the flow of knowledge: Geographic variability in the diffusion of prazosin use for the treatment of post-traumatic stress disorder nationally in the Department of Veterans Affairs. Archives of General Psychiatry April 2009;66(4):417-421.

Both authors are part of the VA Connecticut Healthcare System.

Related Briefs

» next 101 Access Briefs...

» next 171 Medication Briefs...

» next 91 PTSD Briefs...

What are HSR Publication Briefs?

HSR requires notification by HSR-funded investigators about all articles accepted for publication. These journal articles are reviewed by HSR and publication briefs or summaries are written for a select number of articles that are then forwarded to VHA Central Office leadership to keep them informed about important findings or information. Articles to be summarized are selected by HSR based on timeliness of the findings, interest of leadership, or potential impact on the organization. Publication briefs are written for only a small number of HSR published articles. Visit the HSR citations database for a complete listing of HSR articles and presentations.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.